|
1
|
Hu J, Nagarajan D, Zhang Q, Chang JS and
Lee DJ: Heterotrophic cultivation of microalgae for pigment
production: A review. Biotechnol Adv. 36:54–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng YF, Bae SH, Kwon MJ, Park JB, Choi
HD, Shin WG and Bae SK: Inhibitory effects of astaxanthin,
β-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on
cytochrome P450 enzyme activities. Food Chem Toxicol. 59:78–85.
2013. View Article : Google Scholar
|
|
3
|
Guerin M, Huntley ME and Olaizola M:
Haematococcus astaxanthin: Applications for human health and
nutrition. Trends Biotechnol. 21:210–216. 2003. View Article : Google Scholar
|
|
4
|
Boussiba S: Carotenogenesis in the green
alga Haematococcus pluvialis: Cellular physiology and stress
response. Physiol Plant. 108:111–117. 2010. View Article : Google Scholar
|
|
5
|
Higuera-Ciapara I, Félix-Valenzuela L and
Goycoolea FM: Astaxanthin: A review of its chemistry and
applications. Crit Rev Food Sci Nutr. 46:185–196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tume RK, Sikes AL, Tabrett S and Smith DM:
Effect of background colour on the distribution of astaxanthin in
black tiger prawn (Penaeus monodon): Effective method for
improvement of cooked colour. Aquaculture. 296:129–135. 2009.
View Article : Google Scholar
|
|
7
|
Mosaad YO, Gobba NA and Hussein MA:
Astaxanthin; a promising protector against gentamicin-induced
nephrotoxicity in rats. Curr Pharm Biotechnol. 17:1189–1197. 2016.
View Article : Google Scholar
|
|
8
|
Curek GD, Cort A, Yucel G, Demir N, Ozturk
S, Elpek GO, Savas B and Aslan M: Effect of astaxanthin on
hepatocellular injury following ischemia/reperfusion. Toxicology.
267:147–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kishimoto Y, Yoshida H and Kondo K:
Potential anti-atherosclerotic properties of astaxanthin. Mar
Drugs. 14:352016. View Article : Google Scholar
|
|
10
|
Zajac G, Machalska E, Kaczor A, Kessler J,
Bouř P and Baranska M: Structure of supramolecular astaxanthin
aggregates revealed by molecular dynamics and electronic circular
dichroism spectroscopy. Phys Chem Chem Phys. 20:18038–18046. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Armstrong DW and Chang CD: Rapid
baseline separation of enantiomers and a mesoform of
all-trans-astaxanthin, 13-cis-astaxanthin, adonirubin, and
adonixanthin in standards and commercial supplements. J Chromatogr
A. 1194:172–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Luo Q, Cao Y, Goulette T, Liu X and
Xiao H: Mechanism of different stereoisomeric astaxanthin in
resistance to oxidative stress in caenorhabditis elegans. J Food
Sci. 81:H2280–H2287. 2016. View Article : Google Scholar
|
|
13
|
Yuan JP, Peng J, Yin K and Wang JH:
Potential health-promoting effects of astaxanthin: A high-value
carotenoid mostly from microalgae. Mol Nutr Food Res. 55:150–165.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambati RR, Phang SM, Ravi S and
Aswathanarayana RG: Astaxanthin: Sources, extraction, stability,
biological activities and its commercial applications-a review. Mar
Drugs. 12:128–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fakhri S, Abbaszadeh F, Dargahi L and
Jorjani M: Astaxanthin: A mechanistic review on its biological
activities and health benefits. Pharmacol Res. 136:1–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raja R, Hemaiswarya S, Kumar NA, Sridhar S
and Rengasamy R: A perspective on the biotechnological potential of
microalgae. Crit Rev Microbiol. 34:77–88. 2008. View Article : Google Scholar
|
|
17
|
Capelli B, Bagchi D and Cysewski GR:
Synthetic astaxanthin is significantly inferior to algal-based
astaxanthin as an antioxidant and may not be suitable as a human
nutraceutical supplement. Nutrafoods. 12:145–152. 2013. View Article : Google Scholar
|
|
18
|
Baccouche B, Benlarbi M, Barber AJ and Ben
Chaouacha-Chekir R: Short-term administration of astaxanthin
attenuates retinal changes in diet-induced diabetic psammomys
obesus. Curr Eye Res. 43:1177–1189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshihisa Y, Rehman MU and Shimizu T:
Astaxanthin, a xanthophyll carotenoid, inhibits ultraviolet-induced
apoptosis in keratinocytes. Exp Dermatol. 23:178–183. 2014.
View Article : Google Scholar
|
|
20
|
Ito N, Seki S and Ueda F: The protective
role of astaxanthin for UV-induced skin deterioration in healthy
people-a randomized, double-blind, placebo-controlled trial.
Nutrients. 10:8172018. View Article : Google Scholar
|
|
21
|
Bhuvaneswari S, Arunkumar E, Viswanathan P
and Anuradha CV: Astaxanthin restricts weight gain, promotes
insulin sensitivity and curtails fatty liver disease in mice fed a
obesity-promoting diet. Process Biochem. 45:1406–1414. 2010.
View Article : Google Scholar
|
|
22
|
Fan CD, Sun JY, Fu XT, Hou YJ, Li Y, Yang
MF, Fu XY and Sun BL: Astaxanthin attenuates homocysteine-induced
cardiotoxicity in vitro and in vivo by inhibiting mitochondrial
dysfunction and oxidative damage. Front Physiol. 8:10412017.
View Article : Google Scholar
|
|
23
|
Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ,
Lee SW and Bak YT: Astaxanthin inhibits proliferation of human
gastric cancer cell lines by Interrupting cell cycle progression.
Gut Liver. 10:369–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu H, Niu H, Shao A, Wu C, Dixon BJ, Zhang
J, Yang S and Wang Y: Astaxanthin as a potential neuroprotective
agent for neurological diseases. Mar Drugs. 13:5750–5766. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grimmig B, Kim SH, Nash K, Bickford PC and
Douglas Shytle R: Neuroprotective mechanisms of astaxanthin: A
potential therapeutic role in preserving cognitive function in age
and neurodegeneration. Geroscience. 39:19–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khademian M and Imlay JA: How microbes
evolved to tolerate oxygen. Trends Microbiol. 29:428–440. 2021.
View Article : Google Scholar
|
|
27
|
Hammarlund EU, Flashman E, Mohlin S and
Licausi F: Oxygen-sensing mechanisms across eukaryotic kingdoms and
their roles in complex multicellularity. Science. 370:eaba35122020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kamath BS, Srikanta BM, Dharmesh SM,
Sarada R and Ravishankar GA: Ulcer preventive and antioxidative
properties of astaxanthin from Haematococcus pluvialis. Eur
J Pharmacol. 590:387–395. 2008. View Article : Google Scholar
|
|
29
|
Rao AR, Sindhuja HN, Dharmesh SM, Sankar
KU, Sarada R and Ravishankar GA: Effective inhibition of skin
cancer, tyrosinase, and antioxidative properties by astaxanthin and
astaxanthin esters from the green alga Haematococcus
pluvialis. J Agric Food Chem. 61:3842–3851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naguib YM: Antioxidant activities of
astaxanthin and related carotenoids. J Agric Food Chem.
48:1150–1154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakajima Y, Inokuchi Y, Shimazawa M,
Otsubo K, Ishibashi T and Hara H: Astaxanthin, a dietary
carotenoid, protects retinal cells against oxidative stress
in-vitro and in mice in-vivo. J Pharm Pharmacol. 60:1365–1374.
2008. View Article : Google Scholar
|
|
32
|
Ye Q, Zhang X, Huang B, Zhu Y and Chen X:
Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12
cells through a Sp1/NR1 signaling pathway. Mar Drugs. 11:1019–1034.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zarneshan SN, Fakhri S, Farzaei MH, Khan H
and Saso L: Astaxanthin targets PI3K/Akt signaling pathway toward
potential therapeutic applications. Food Chem Toxicol.
145:1117142020. View Article : Google Scholar
|
|
34
|
Wu Q, Zhang XS, Wang HD, Zhang X, Yu Q, Li
W, Zhou ML and Wang XL: Astaxanthin activates nuclear factor
erythroid-related factor 2 and the antioxidant responsive element
(Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in
rats and attenuates early brain injury. Mar Drugs. 12:6125–6141.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y,
Hou D and Zhang X: Astaxanthin protects ARPE-19 cells from
oxidative stress via upregulation of Nrf2-regulated phase II
enzymes through activation of PI3K/Akt. Mol Vis. 19:1656–1666.
2013.PubMed/NCBI
|
|
36
|
Wang HQ, Sun XB, Xu YX, Zhao H, Zhu QY and
Zhu CQ: Astaxanthin upregulates heme oxygenase-1 expression through
ERK1/2 pathway and its protective effect against
beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res.
1360:159–167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Al-Amin MM, Mahmud W, Pervin MS, Ridwanul
Islam SM, Ashikur Rahman M and Zinchenko A: Astaxanthin ameliorates
scopolamine-induced spatial memory deficit via reduced
cortical-striato-hippocampal oxidative stress. Brain Res.
1710:74–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim SH, Lim JW and Kim H: Astaxanthin
inhibits mitochondrial dysfunction and interleukin-8 expression in
helicobacter pylori-infected gastric epithelial cells. Nutrients.
10:13202018. View Article : Google Scholar
|
|
39
|
Ranga Rao A, Raghunath Reddy RL, Baskaran
V, Sarada R and Ravishankar GA: Characterization of microalgal
carotenoids by mass spectrometry and their bioavailability and
antioxidant properties elucidated in rat model. J Agric Food Chem.
58:8553–8559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Netea MG, Balkwill F, Chonchol M,
Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, Golenbock D,
Gresnigt MS, Heneka MT, Hoffman HM, et al: A guiding map for
inflammation. Nat Immunol. 18:826–831. 2017. View Article : Google Scholar
|
|
41
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar
|
|
42
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: Evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar
|
|
43
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther.
2:170232017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang C, Hassan YI, Liu R, Zhang H, Chen Y,
Zhang L and Tsao R: Anti-inflammatory effects of different
astaxanthin isomers and the roles of lipid transporters in the
cellular transport of astaxanthin isomers in Caco-2 cell
monolayers. J Agric Food Chem. 67:6222–6231. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Grilo AL and Mantalaris A: Apoptosis: A
mammalian cell bioprocessing perspective. Biotechnol Adv.
37:459–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Adams JM and Cory S: The BCL-2 arbiters of
apoptosis and their growing role as cancer targets. Cell Death
Differ. 25:27–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View Article : Google Scholar
|
|
49
|
Zhang L and Wang H: Multiple mechanisms of
anti-cancer effects exerted by astaxanthin. Mar Drugs.
13:4310–4330. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dong LY, Jin J, Lu G and Kang XL:
Astaxanthin attenuates the apoptosis of retinal ganglion cells in
db/db mice by inhibition of oxidative stress. Mar Drugs.
11:960–974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Guo SX, Zhou HL, Huang CL, You CG, Fang Q,
Wu P, Wang XG and Han CM: Astaxanthin attenuates early acute kidney
injury following severe burns in rats by ameliorating oxidative
stress and mitochondrial-related apoptosis. Mar Drugs.
13:2105–2123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang XS, Zhang X, Wu Q, Li W, Zhang QR,
Wang CX, Zhou XM, Li H, Shi JX and Zhou ML: Astaxanthin alleviates
early brain injury following subarachnoid hemorrhage in rats:
Possible involvement of Akt/bad signaling. Mar Drugs. 12:4291–4310.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li S, Takahara T, Fujino M, Fukuhara Y,
Sugiyama T, Li XK and Takahara S: Astaxanthin prevents
ischemia-reperfusion injury of the steatotic liver in mice. PLoS
One. 12:e01878102017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Klein RS and Hunter CA: Protective and
pathological immunity during central nervous system infections.
Immunity. 46:891–909. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Manabe Y, Komatsu T, Seki S and Sugawara
T: Dietary astaxanthin can accumulate in the brain of rats. Biosci
Biotechnol Biochem. 82:1433–1436. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
El-Agamy SE, Abdel-Aziz AK, Wahdan S,
Esmat A and Azab SS: Astaxanthin ameliorates doxorubicin-induced
cognitive impairment (Chemobrain) in experimental rat model: Impact
on oxidative, inflammatory, and apoptotic machineries. Mol
Neurobiol. 55:5727–5740. 2018. View Article : Google Scholar
|
|
57
|
Lee H, Lim JW and Kim H: Effect of
astaxanthin on activation of autophagy and inhibition of apoptosis
in helicobacter pylori-infected gastric epithelial cell line AGS.
Nutrients. 12:17502020. View Article : Google Scholar
|
|
58
|
Damodara Gowda KM, Suchetha Kumari N and
Ullal H: Role of astaxanthin in the modulation of brain-derived
neurotrophic factor and spatial learning behavior in perinatally
undernourished Wistar rats. Nutr Neurosci. 23:422–431. 2020.
View Article : Google Scholar
|
|
59
|
Wang YL, Zhu XL, Sun MH and Dang YK:
Effects of astaxanthin onaxonal regeneration via cAMP/PKA signaling
pathway in mice with focal cerebral infarction. Eur Rev Med
Pharmacol Sci. 23 (3 Suppl):S135–S143. 2019.
|
|
60
|
Cullen DK, Simon CM and LaPlaca MC: Strain
rate-dependent induction of reactive astrogliosis and cell death in
three-dimensional neuronal-astrocytic co-cultures. Brain Res.
1158:103–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ahmed S, Reynolds BA and Weiss S: BDNF
enhances the differentiation but not the survival of CNS stem
cell-derived neuronal precursors. J Neurosci. 15:5765–5778. 1995.
View Article : Google Scholar
|
|
62
|
Tublin JM, Adelstein JM, Del Monte F,
Combs CK and Wold LE: Getting to the heart of Alzheimer disease.
Circ Res. 124:142–149. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Alzheimer's Association: 2016 Alzheimer's
disease facts and figures. Alzheimers Dement. 12:459–509. 2016.
View Article : Google Scholar
|
|
64
|
Jia J, Wang F, Wei C, Zhou A, Jia X, Li F,
Tang M, Chu L, Zhou Y, Zhou C, et al: The prevalence of dementia in
urban and rural areas of China. Alzheimers Dement. 10:1–9. 2014.
View Article : Google Scholar
|
|
65
|
Nakamura A, Kaneko N, Villemagne VL, Kato
T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, et al:
High performance plasma amyloid-β biomarkers for Alzheimer's
disease. Nature. 554:249–254. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Butterfield DA, Castegna A, Lauderback CM
and Drake J: Evidence that amyloid beta-peptide-induced lipid
peroxidation and its sequelae in Alzheimer's disease brain
contribute to neuronal death. Neurobiol Aging. 23:655–664. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Pradeepkiran JA and Reddy PH: Defective
mitophagy in Alzheimer's disease. Ageing Res Rev. 64:1011912020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Squitti R, Mendez A, Ricordi C, Siotto M
and Goldberg R: Copper in glucose intolerance, cognitive decline,
and Alzheimer disease. Alzheimer Dis Assoc Disord. 33:77–85. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bjørklund G, Dadar M, Peana M, Rahaman MS
and Aaseth J: Interactions between iron and manganese in
neurotoxicity. Arch Toxicol. 94:725–734. 2020. View Article : Google Scholar
|
|
70
|
Khan MM, Xiao J, Patel D and LeDoux MS:
DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.
Neurobiol Aging. 62:180–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Ito N, Saito H, Seki S, Ueda F and Asada
T: Effects of composite supplement containing astaxanthin and
sesamin on cognitive functions in people with mild cognitive
impairment: A randomized, double-blind, placebo-controlled trial:
Erratum. J Alzheimers Dis. 68:8392019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sekikawa T, Kizawa Y, Li Y and Takara T:
Cognitive function improvement with astaxanthin and tocotrienol
intake: A randomized, double-blind, placebo-controlled study. J
Clin Biochem Nutr. 67:307–316. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Taksima T, Chonpathompikunlert P, Sroyraya
M, Hutamekalin P, Limpawattana M and Klaypradit W: Effects of
astaxanthin from shrimp shell on oxidative stress and behavior in
animal model of Alzheimer's disease. Mar Drugs. 17:6282019.
View Article : Google Scholar
|
|
74
|
Kellar D and Craft S: Brain insulin
resistance in Alzheimer's disease and related disorders: Mechanisms
and therapeutic approaches. Lancet Neurol. 19:758–766. 2020.
View Article : Google Scholar
|
|
75
|
Rahman SO, Panda BP, Parvez S, Kaundal M,
Hussain S, Akhtar M and Najmi AK: Neuroprotective role of
astaxanthin in hippocampal insulin resistance induced by Aβ
peptides in animal model of Alzheimer's disease. Biomed
Pharmacother. 110:47–58. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Craft S and Watson GS: Insulin and
neurodegenerative disease: Shared and specific mechanisms. Lancet
Neurol. 3:169–178. 2004. View Article : Google Scholar
|
|
77
|
Kim RE, Shin CY, Han SH and Kwon KJ:
Astaxanthin suppresses PM2.5-induced neuroinflammation by
regulating Akt phosphorylation in BV-2 microglial cells. Int J Mol
Sci. 21:72272020. View Article : Google Scholar
|
|
78
|
Kim YH, Koh HK and Kim DS: Down-regulation
of IL-6 production by astaxanthin via ERK-, MSK-, and
NF-κB-mediated signals in activated microglia. Int Immunopharmacol.
10:1560–1572. 2010. View Article : Google Scholar
|
|
79
|
Wen X, Huang A, Hu J, Zhong Z, Liu Y, Li
Z, Pan X and Liu Z: Neuroprotective effect of astaxanthin against
glutamate-induced cytotoxicity in HT22 cells: Involvement of the
Akt/GSK-3β pathway. Neuroscience. 303:558–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ascherio A and Schwarzschild MA: The
epidemiology of Parkinson's disease: Risk factors and prevention.
Lancet Neurol. 15:1257–1272. 2016. View Article : Google Scholar
|
|
81
|
Samii A, Nutt JG and Ransom BR:
Parkinson's disease. Lancet. 363:1783–1793. 2004. View Article : Google Scholar
|
|
82
|
Sayre LM, Smith MA and Perry G: Chemistry
and biochemistry of oxidative stress in neurodegenerative disease.
Curr Med Chem. 8:721–738. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Issa AR, Sun J, Petitgas C, Mesquita A,
Dulac A, Robin M, Mollereau B, Jenny A, Chérif-Zahar B and Birman
S: The lysosomal membrane protein LAMP2A promotes autophagic flux
and prevents SNCA-induced Parkinson disease-like symptoms in the
Drosophila brain. Autophagy. 14:1898–1910. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ye Q, Huang B, Zhang X, Zhu Y and Chen X:
Astaxanthin protects against MPP(+)-induced oxidative stress in
PC12 cells via the HO-1/NOX2 axis. BMC Neurosci. 13:1562012.
View Article : Google Scholar
|
|
85
|
Brasil FB, Bertolini Gobbo RC, Souza de
Almeida FJ, Luckachaki MD, Dall'Oglio EL and de Oliveira MR: The
signaling pathway PI3K/Akt/Nrf2/HO-1 plays a role in the
mitochondrial protection promoted by astaxanthin in the SH-SY5Y
cells exposed to hydrogen peroxide. Neurochem Int. 146:1050242021.
View Article : Google Scholar
|
|
86
|
Lee DH, Kim CS and Lee YJ: Astaxanthin
protects against MPTP/MPP+-induced mitochondrial dysfunction and
ROS production in vivo and in vitro. Food Chem Toxicol. 49:271–280.
2011. View Article : Google Scholar
|
|
87
|
Kim JH, Hwang J, Shim E, Chung EJ, Jang SH
and Koh SB: Association of serum carotenoid, retinol, and
tocopherol concentrations with the progression of Parkinson's
disease. Nutr Res Pract. 11:114–120. 2017. View Article : Google Scholar
|
|
88
|
Campbell BCV, De Silva DA, Macleod MR,
Coutts SB, Schwamm LH, Davis SM and Donnan GA: Ischaemic stroke.
Nat Rev Dis Primers. 5:702019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
George PM and Steinberg GK: Novel stroke
therapeutics: Unraveling stroke pathophysiology and its impact on
clinical treatments. Neuron. 87:297–309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lazou A, Bogoyevitch MA, Clerk A, Fuller
SJ, Marshall CJ and Sugden PH: Regulation of mitogen-activated
protein kinase cascade in adult rat heart preparations in vitro.
Circ Res. 75:932–941. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang R, Liu C, Liu X and Guo Y:
Protective effect of spatholobus suberectus on brain tissues in
cerebral ischemia. Am J Transl Res. 8:3963–3969. 2016.PubMed/NCBI
|
|
92
|
Vani JR, Mohammadi MT, Foroshani MS and
Jafari M: Polyhydroxylated fullerene nanoparticles attenuate brain
infarction and oxidative stress in rat model of ischemic stroke.
EXCLI J. 15:378–390. 2016.PubMed/NCBI
|
|
93
|
Xue Y, Qu Z, Fu J, Zhen J and Wang W, Cai
Y and Wang W: The protective effect of astaxanthin on learning and
memory deficits and oxidative stress in a mouse model of repeated
cerebral ischemia/reperfusion. Brain Res Bull. 131:221–228. 2017.
View Article : Google Scholar
|
|
94
|
Pan L, Zhou Y, Li XF, Wan QJ and Yu LH:
Preventive treatment of astaxanthin provides neuroprotection
through suppression of reactive oxygen species and activation of
antioxidant defense pathway after stroke in rats. Brain Res Bull.
130:211–220. 2017. View Article : Google Scholar
|
|
95
|
Lee DH, Lee YJ and Kwon KH:
Neuroprotective effects of astaxanthin in oxygen-glucose
deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J
Clin Biochem Nutr. 47:121–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Lu YP, Liu SY, Sun H, Wu XM, Li JJ and Zhu
L: Neuroprotective effect of astaxanthin on H(2)O(2)-induced
neurotoxicity in vitro and on focal cerebral ischemia in vivo.
Brain Res. 1360:40–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yang BB, Zou M, Zhao L and Zhang YK:
Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1
pathway in rats. Curr Res Transl Med. 69:1032712021. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Budohoski KP, Guilfoyle M, Helmy A,
Huuskonen T, Czosnyka M, Kirollos R, Menon DK, Pickard JD and
Kirkpatrick PJ: The pathophysiology and treatment of delayed
cerebral ischaemia following subarachnoid haemorrhage. J Neurol
Neurosurg Psychiatry. 85:1343–1353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Vergouwen MD, Ilodigwe D and Macdonald RL:
Cerebral infarction after subarachnoid hemorrhage contributes to
poor outcome by vasospasm-dependent and -independent effects.
Stroke. 42:924–929. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Chen S, Feng H, Sherchan P, Klebe D, Zhao
G, Sun X, Zhang J, Tang J and Zhang JH: Controversies and evolving
new mechanisms in subarachnoid hemorrhage. Prog Neurobiol.
115:64–91. 2014. View Article : Google Scholar
|
|
101
|
Serrone JC, Maekawa H, Tjahjadi M and
Hernesniemi J: Aneurysmal subarachnoid hemorrhage: Pathobiology,
current treatment and future directions. Expert Rev Neurother.
15:367–380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang X, Lu Y, Wu Q, Dai H, Li W, Lv S,
Zhou X, Zhang X, Hang C and Wang J: Astaxanthin mitigates
subarachnoid hemorrhage injury primarily by increasing sirtuin 1
and inhibiting the Toll-like receptor 4 signaling pathway. FASEB J.
33:722–737. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhang XS, Zhang X, Zhou ML, Zhou XM, Li N,
Li W, Cong ZX, Sun Q, Zhuang Z, Wang CX and Shi JX: Amelioration of
oxidative stress and protection against early brain injury by
astaxanthin after experimental subarachnoid hemorrhage. J
Neurosurg. 121:42–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wang Y, Liu Y, Li Y, Liu B, Wu P, Xu S and
Shi H: Protective effects of astaxanthin on subarachnoid
hemorrhage-induced early brain injury: Reduction of cerebral
vasospasm and improvement of neuron survival and mitochondrial
function. Acta Histochem. 121:56–63. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Hardiman O, Al-Chalabi A, Chio A, Corr EM,
Logroscino G, Robberecht W, Shaw PJ, Simmons Z and van den Berg LH:
Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 3:170712017.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Arthur KC, Calvo A, Price TR, Geiger JT,
Chiò A and Traynor BJ: Projected increase in amyotrophic lateral
sclerosis from 2015 to 2040. Nat Commun. 7:124082016. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Nuevo Ordoñez Y, Montes-Bayón M,
Blanco-González E and Sanz-Medel A: Quantitative analysis and
simultaneous activity measurements of Cu, Zn-superoxide dismutase
in red blood cells by HPLC-ICPMS. Anal Chem. 82:2387–2394. 2010.
View Article : Google Scholar
|
|
108
|
Bond L, Bernhardt K, Madria P, Sorrentino
K, Scelsi H and Mitchell CS: A metadata analysis of oxidative
stress etiology in preclinical amyotrophic lateral sclerosis:
Benefits of antioxidant therapy. Front Neurosci. 12:102018.
View Article : Google Scholar
|
|
109
|
Isonaka R, Hiruma H, Katakura T and
Kawakami T: Inhibition of superoxide dismutase selectively
suppresses growth of rat spinal motor neurons: Comparison with
phosphorylated neurofilament-containing spinal neurons. Brain Res.
1425:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Fitzgerald KC, O'Reilly ÉJ, Fondell E,
Falcone GJ, McCullough ML, Park Y, Kolonel LN and Ascherio A:
Intakes of vitamin C and carotenoids and risk of amyotrophic
lateral sclerosis: Pooled results from 5 cohort studies. Ann
Neurol. 73:236–245. 2013. View Article : Google Scholar
|
|
111
|
Nieves JW, Gennings C, Factor-Litvak P,
Hupf J, Singleton J, Sharf V, Oskarsson B, Fernandes Filho JA,
Sorenson EJ, D'Amico E, et al: Association between dietary intake
and function in amyotrophic lateral sclerosis. JAMA Neurol.
73:1425–1432. 2016. View Article : Google Scholar
|
